Market Closed -
Nasdaq Helsinki
12:29:30 2024-03-18 pm EDT
Pre-market
03:30:54 am
25.22
EUR
-0.55%
25.2
-0.08%
Sales 2024 *
105M
114M
Sales 2025 *
119M
129M
Capitalization
671M
729M
Net income 2024 *
21M
22.82M
Net income 2025 *
27M
29.34M
EV / Sales 2024 *
6.18
x
Net cash position
2024
*
22.35M
24.28M
Net cash position
2025
*
38.57M
41.91M
EV / Sales 2025 *
5.32
x P/E ratio 2024 *
31.3
x
P/E ratio 2025 *
24.8
x
Employees
207
Yield 2024 *
1.59%
Yield 2025 *
1.89%
Free-Float
79.22%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Revenio Group Oyj Proposes Dividend for the Year Ended December 31, 2023, Payable on April 15, 2024
Mar. 12
CI
Transcript : Revenio Group Oyj, 2023 Earnings Call, Feb 15, 2024
Feb. 15
Revenio Group Oyj to Propose Dividend
Feb. 15
CI
Revenio Group Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 15
CI
Revenio Group Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 15
CI
Revenio Unit, iCare Enter Partnership Deal for AI Retinal Screening Service
Jan. 26
MT
Revenio Group Seeks M&A Opportunities
Nov. 30
CI
Transcript : Revenio Group Oyj - Analyst/Investor Day
Nov. 30
Transcript : Revenio Group Oyj, Q3 2023 Earnings Call, Oct 26, 2023
23-10-26
Revenio Group Oyj Provides Earnings Guidance for the Year 2023
23-10-26
CI
Revenio Group Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
23-10-26
CI
Transcript : Revenio Group Oyj, H1 2023 Earnings Call, Aug 10, 2023
23-08-10
Revenio Group Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-10
CI
Revenio Group Corporation Expands the Ai-Aided iCare Illume Screening Solution's Applications
23-06-07
CI
Revenio, OphtAI Enter Distribution Partnership for Retinal Image Analysis
23-05-08
MT
More news
Stop ou encore ?
Mar. 14
AVIS D'ANALYSTES DU JOUR : LVMH, Sanofi, Kering, Roche, Novartis, Stellantis, AXA, Edenred...
Mar. 14
OPINIONES DE LOS ANALISTAS DEL DÍA : Adidas, Inditex, Aena, LVMH, BHP, Kering, Roche, Poste Italiane, Stellantis, RWE...
Mar. 14
Bolsa de Madrid: ¿Parar o continuar?
Mar. 14
Ça baisse plus
Feb. 16
More news 1 day -0.16%
1 week -1.56%
Current month -2.78%
1 month -6.25%
3 months -6.59%
6 months +16.98%
Current year -7.14%
More quotes
Managers
Title Age Since
Chief Executive Officer
56
20-09-29
Director of Finance/CFO
44
15-07-14
Chief Operating Officer
58
16-05-31
Members of the board
Title Age Since
Chairman
55
20-06-07
Director/Board Member
60
16-03-14
Director/Board Member
62
07-04-02
More insiders
Date
Price
Change
Volume
24-03-18
25.22
-0.55%
19,315
24-03-15
25.36
-1.17%
37,009
24-03-14
25.66
+0.31%
17,927
24-03-13
25.58
-1.77%
14,322
24-03-12
26.04
+1.64%
12,120
Delayed Quote
Nasdaq Helsinki, March 18, 2024 at 12:29 pm EDT
More quotes
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company's activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
More about the company
Last Close Price
25.22
EUR
Average target price
29.06
EUR
Spread / Average Target
+15.23%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1